Sequential pulmonary functions in survivors of leptospirosis pulmonary haemorrhage syndrome: a prospective cohort study
- PMID: 39696512
- PMCID: PMC11657222
- DOI: 10.1186/s41182-024-00665-6
Sequential pulmonary functions in survivors of leptospirosis pulmonary haemorrhage syndrome: a prospective cohort study
Abstract
Background: Leptospirosis, a spirochaete infection, can lead to Leptospirosis Pulmonary Haemorrhage Syndrome (LPHS), which requires intensive care admission and has a high mortality. Although data on short-term outcomes are available, the long-term respiratory sequelae of LPHS survivors are not known. We aimed to identify the post-discharge pulmonary functions and functional limitations in survivors of LPHS.
Methods: We conducted a prospective cohort study from January to December 2022 at the Medical Intensive Care Unit (ICU) of the National Hospital of Sri Lanka to assess the sequential changes in the spirometry parameters in patients who survived LPHS. The Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 s (FEV1) were measured on the day of discharge from the ICU (D0), 7th day after discharge (D7) and 28th day after discharge (D28). The predicted lung volume was calculated using the gender, age and height as per standard protocol. Physical and functional role limitations were assessed on D28 using the modified Medical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36).
Results: Twenty-one patients with a mean age of 44 years (SD 16.07) were enrolled for the study. The majority were male patients (n = 19, 90.5%). Leptospirosis was serologically confirmed in all individuals. Seventeen (81%) patients had reduced FEV1 and FVC on D0, indicating a restrictive lung abnormality. FVC and FEV1 improved during the first 7 days (p < 0.01) but did not change significantly afterwards. Only seven individuals (33.3%) achieved a normal FVC (exceeding 80% of the predicted volume) at D28. However, 19 (90.5%) individuals achieved a normal FEV1 (exceeding 80% of predicted volume) by D28. In our study, administering corticosteroids during ICU stay did not impact lung recovery in FVC (p = 0.521) or FEV1 (p = 0.798). The participants did not have significant physical, functional, and role limitations at D28.
Conclusions: The spirometry measurements of individuals diagnosed with LPHS significantly improved during the first 7 days. Most survivors did not have a functional impairment despite the FVC not recovering to normal by D28.
Keywords: FEV1; FVC; Leptospirosis; Lung function; Pulmonary haemorrhage.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical clearance was obtained from the ethics review committee of the National Hospital of Sri Lanka. The study was conducted in accordance with the Declaration of Helsinki. Consent for publication: Informed written consent was taken from the patients to publish anonymised data. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 38309959 Chinese.
-
Long-Term Pulmonary Sequelae and Immunological Markers in Patients Recovering from Severe and Critical COVID-19 Pneumonia: A Comprehensive Follow-Up Study.Medicina (Kaunas). 2024 Nov 27;60(12):1954. doi: 10.3390/medicina60121954. Medicina (Kaunas). 2024. PMID: 39768836 Free PMC article.
-
Spirometry not pain level predicts outcomes in geriatric patients with isolated rib fractures.J Trauma Acute Care Surg. 2020 Nov;89(5):947-954. doi: 10.1097/TA.0000000000002795. J Trauma Acute Care Surg. 2020. PMID: 32467465
-
Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study.Lancet Respir Med. 2023 Mar;11(3):273-282. doi: 10.1016/S2213-2600(22)00364-2. Epub 2022 Oct 14. Lancet Respir Med. 2023. PMID: 36244396
-
Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241254212. doi: 10.1177/17534666241254212. Ther Adv Respir Dis. 2024. PMID: 38841799 Free PMC article.
References
-
- Pereira Da Silva JJ, Dalston MO, De Carvalho JEM, Setúbal S, De Oliveira JMC, Pereira MM. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop. 2002;35:395–9. 10.1590/S0037-86822002000400017. - PubMed
-
- Herath N, Uluwattage W, Weliwitiya T, Karunanayake L, Lekamwasam S, Ratnatunga N, et al. Sequel and therapeutic modalities of leptospirosis associated severe pulmonary haemorrhagic syndrome (SPHS); a Sri Lankan experience. BMC Infect Dis. 2019;19:1–8. 10.1186/S12879-019-4094-0/TABLES/7. - PMC - PubMed
-
- Dolhnikoff M, Mauad T, Bethlem EP, Carvalho CRR. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Braz J Infect Dis. 2007;11:142–8. 10.1590/S1413-86702007000100029. - PubMed
LinkOut - more resources
Full Text Sources